Clin2
NCT07869381Possibly a fitNot yet recruiting

Comparing two ways to examine melanoma removal samples

Cutaneous Melanoma, Stage IICutaneous MelanomaAcral Melanoma

Part of Cancer, Skin clinical trials.

This trial tests two methods of checking removed melanoma tissue to see which gives clearer results. It may help improve how doctors determine if all cancer was removed.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
282 people
Ages
19 years and older
Study type
Interventional

Who can take part

  • You are 19 years or older.
  • You have stage 1 or 2 melanoma (including acral melanoma) confirmed by biopsy.
  • You are scheduled for a standard wide local excision to remove more tissue around the melanoma.
  • You have not had a prior wide local excision for this melanoma.
  • You have no history of melanoma before this one.
  • You have melanoma only at one site.
  • You have not had radiation therapy to the area where the melanoma is.
  • You are not pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03860883Recruiting
Comparing wider versus narrower surgery margins for stage II melanoma

This trial studies whether removing a slightly wider strip of skin around a melanoma improves outcomes compared with a narrower strip. It also uses a lymph node staging procedure to check spread and helps doctors fine-tune surgery for stage II melanoma.

Mobile, Alabama
NCT07068074Recruiting· Phase 3
Comparing less invasive surgery to standard care for older adults with early-stage melanoma

This trial compares less invasive procedures with the current standard treatment for early-stage melanoma in adults 75 and older. The goal is to find out if these less invasive options work just as well and help patients recover better.

Birmingham, Alabama
NCT06319196Recruiting· Phase 2
Clearing melanoma with immunotherapy after surgery

This trial tests whether a combination of two immunotherapy drugs (nivolumab and relatlimab) can clear tiny amounts of cancer cells that remain after surgery in people with high-risk melanoma. It aims to prevent the cancer from coming back.

Toronto, Ontario
NCT07621614Recruiting· Phase 2
Safe Surgery Guidance for Childhood Melanoma Using Genetics

This study helps doctors decide the safest surgical approach for melanoma and similar skin tumors in children and young adults by using pathology reports and genetic information. The goal is to avoid unnecessary surgery while ensuring the best outcomes.

Oakland, California
NCT05253872Recruiting
Danish study to track early melanoma after surgery

This study tests a new way to monitor people after surgery for early-stage melanoma. If you qualify, it may help your doctors watch for changes sooner or more accurately during follow-up.

Copenhagen
NCT06673095Recruiting
Narrow vs wide surgery for invasive skin melanoma

This trial compares two surgeries for invasive melanoma: a narrow removal versus a wider one. It aims to see if a smaller surgery works as well, which could mean less scarring and recovery time.

Davis, California

Hear when a new Cutaneous Melanoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.